Posts tagged Motilal Oswal
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| Research Reports On Allcargo Global Logistics By Motilal Oswal, Religare & PL | |
| Company: | Allcargo Global Logistics |
| Brokerage: | Motilal Oswal, Prabhudas Lilladher, Religare |
| Date of report: | October 24, 2017 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 25% |
| Summary: | Contract logistics, land monetization to add value. Management initiatives to improve return ratios |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Allcargo Global Logistics, Prabhudas Lilladher, Religare |
| Motilal Oswal Diwali Dhamaka Stock Recommendations 2017 | |
| Company: | - |
| Brokerage: | Motilal Oswal |
| Date of report: | October 13, 2017 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 47% |
| Summary: | TOP PICKS FOR DIWALI, SAMVAT 2074 |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Diwali Dhamaka |
| Shilpa Medicare Initiating Coverage Research Report By Motilal Oswal | |
| Company: | Shilpa Medicare |
| Brokerage: | Motilal Oswal |
| Date of report: | July 31, 2017 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 24% |
| Summary: | Product approvals, superior execution to drive earnings |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Shilpa Medicare |
| Trident Ltd Research Reports By Motilal Oswal, Edelweiss & IDBI Capital | |
| Company: | Trident Ltd |
| Brokerage: | Edelweiss, IDBI Capital, Motilal Oswal |
| Date of report: | August 23, 2017 |
| Type of Report: | Initiating Coverage, Result Update |
| Recommendation: | Buy |
| Upside Potential: | 51% |
| Summary: | An attractive utilization play |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Edelweiss, IDBI Capital, Trident Ltd |
| Granules India Research Reports By Edelweiss, Motilal Oswal, HDFC Sec + Investors Presentation | |
| Company: | Granules India |
| Brokerage: | Edelweiss, HDFC Sec, Motilal Oswal |
| Date of report: | August 14, 2017 |
| Type of Report: | Initiating Coverage, Investors' Presentation, Result Update |
| Recommendation: | Buy |
| Upside Potential: | 88% |
| Summary: | Strong quarter aided with improved product mix |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Edelweiss, Granules India, HDFC Sec |
| Jubilant Life Sciences Research Reports By Motilal Oswal & ICICI-Direct | |
| Company: | Jubilant Life Sciences |
| Brokerage: | ICICI-Direct, Motilal Oswal |
| Date of report: | July 19, 2017 |
| Type of Report: | Initiating Coverage, Result Update |
| Recommendation: | Buy |
| Upside Potential: | 31% |
| Summary: | Multiple triggers in place to drive earnings |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | ICICI-Direct, Jubilant Life Sciences |
| Research Reports On ENIL & Music Broadcast By Motilal Oswal & ICICI-Direct | |
| Company: | ENIL, Entertainment Network, Music Broadcast, Radio City, Radio Mirchi |
| Brokerage: | ICICI-Direct, Motilal Oswal |
| Date of report: | June 7, 2017 |
| Type of Report: | Initiating Coverage, Result Update |
| Recommendation: | Buy |
| Upside Potential: | 25% |
| Summary: | Bet on expanding radio reach… |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | ENIL, Entertainment Network, ICICI-Direct, Music Broadcast, Radio City, Radio Mirchi |
| Manpasand Beverages Research Reports By Motilal Oswal & Ventura | |
| Company: | Manpasand Beverages |
| Brokerage: | Motilal Oswal, Ventura |
| Date of report: | May 9, 2017 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 48% |
| Summary: | Growth continues to remain strong; Maintain buy |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Manpasand Beverages, Ventura |
| Aurobindo Pharma Research Reports + Investors Presentation (Feb 2017) | |
| Company: | Aurobindo Pharma |
| Brokerage: | Axis Direct, Axis Securities, Centrum, ICICI-Direct, IndiaNivesh, Khambatta Securities, Motilal Oswal |
| Date of report: | February 21, 2017 |
| Type of Report: | Investors' Presentation, Result Update |
| Recommendation: | Buy |
| Upside Potential: | 57% |
| Summary: | Strong earnings growth trajectory, improving cash flows to drive valuations |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Aurobindo Pharma, Axis Securities, Centrum, ICICI-Direct, Indianivesh, Khambatta Securities |
| Federal Bank Research Report By Motilal Oswal | |
| Company: | Federal Bank |
| Brokerage: | Motilal Oswal |
| Date of report: | January 20, 2017 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 36% |
| Summary: | Strong balance sheet and core PPoP growth; Stable asset quality |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Federal Bank |